Dipeptidyl peptidase-1 inhibition…om the WILLOW trial.
🔬 Peer-reviewed
Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
Cipolla D, Zhang J, Korkmaz B, Chalmers JD, Basso J et al.
Respiratory research · 2023
Findings
PubMed study on Salix Alba (Willow) Extract in cosmetics/dermatology
Design
Randomized Controlled Trial
Evidence
Moderate
Journal
Respiratory research
Ingredients studied